ASIC1 and myeloid sarcoma: Also, administration of ASIC blocker amiloride attenuated demyelination and neuronal damage in EAE animal model as well as in a cohort of MS patients (Arun et al., 2013), indicating that ASIC1a inhibition is neuroprotective and represents a promising therapeutic strategy for MS.